That was higher than its previous bid of up to $9 billion which sparked a lawsuit from pfizer. The deal comes three days after novo nordisk raised the stakes in its push to outbid pfizer, saying tuesday it would offer to pay as much as $10 billion for metsera. The announcement of the deal signaled an end to the bidding war for metsera between pfizer and novo nordisk, the danish maker of ozempic and wegovy.
instagram: @armzbro - Tumbex
Metsera accepted a sweetened offer from.
Under terms of a deal announced late friday, pfizer will acquire metsera for up to $86.25 per share, or more than $10 billion.
Pfizer wins $10 billion bid for metsera, securing entry into the booming obesity drug market Novo nordisk withdraws over us antitrust risks after a heated bidding war. Agreed to buy metsera inc For up to $10 billion, prevailing over novo nordisk a/s in a tumultuous bidding war after us regulatory opposition thwarted the danish drugmaker’s rival.
